StageZero Life Sciences Ltd T.SZLS

AND DOWN WE GO AGAIN

[Stockish12]

It is now moving in the opposite direction of the market. lol

If you cannot explain why this stock is not above $1.50 right now on the expected news of a 'ground breaking' product like Aristotle, is the same way you will not be able to explain why Aristotle is unsucessful after its release.

I keep telling everyone, this is a good product in the hands of the wrong people. Tripp is not CEO worthy and will fail.

Building  a product behind the scenes and taking that product to the market requires two different set of skills. Some CEOs possess both, Tripp does not have the latter.

However, the dumb 'price can only go up' investors will just call me a basher.

[VerifiedUser123]

Yup. They are dumb and will call you a badger. 

[VerifiedUser123]

*basher

[Educatedopinion]

So , out of the goodness of your heart , you want to protect other investors from  this stock because you are a nice guy and you have no ulterior motive.  If you own the stock and don't like the company , sell and move on . And if you don't own it , why do you care what it does , go play somewhere else and stop spewing vitriol .

[Stockish12]

I own the stock but I am not one of people like you that cannot criticize a stock they own. Except you are a newbie or just a dummy. Picture the product (aristotle) and picture the CEO (Tripp). Can this CEO sell this to US institutional investors? If you think yes, then you are dumber than I thought. 

[Educatedopinion]

So you don't like the CEO , don't like the company and the way it is run but you own the stock and hang on to it because you are a sucker for punishement . But that is not enough  , because of your stellar qualifications , you feel that you are an authority on how the company should be run . You don't know me and definitely don't know James , if you did , you would not spew

[Stockish12]

How do I explain this to this kid? ARISTOTLE IS A GREAT PRODUCT. I am invested cos of the product. My average is .06 pre consolidation. I sold a lot between $1.2 and $1.35 to get my principal with lots of profit. Whats left is what I am willing to risk. That is the risk I am willing to take. I am thinking you are not vast with NASDQ/NYSE investments. If you were, you will not be arguing on the

[Educatedopinion]

When you resort to calling people names, that means you are out of argument and want to bully your point . Yes Aristtole is a great product , and we are nowhere close to Nasdaq listing . Before venturing down that road , the stock needs US exposure and the best bang for the buck initially will be OTCQB . That will at least allow US investors to buy the stock and will give it a boost , OTCQX and

[Stockish12]

well maybe if you decide to be objective, you will have an idea of what I am saying. You are emotionally attached to the stock. Aristotle for cancer alone in the pre-launch state with no revs should have this trading above $2. Now you add covid testing to it and it is still trading below $1? That is most definitely an eyesore. I mentioned how the CO lacks capacity right? Lets look at an example